Healthcare provider profile · identity verified

Alec Pruchnicki, MD

Internal Medicine · NEW YORK, NY · NPI 1104934736

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	616	85
Metoprolol Succinate	Metoprolol Succinate	427	54
Levothyroxine Sodium	Levothyroxine Sodium	299	40
Amlodipine Besylate	Amlodipine Besylate	274	37
Lisinopril	Lisinopril	265	41
Eliquis	Apixaban	217	30
Tamsulosin Hcl	Tamsulosin Hcl	205	29
Furosemide	Furosemide	192	26
Gabapentin	Gabapentin	188	26
Pantoprazole Sodium	Pantoprazole Sodium	187	26
Omeprazole	Omeprazole	154	21
Metformin Hcl	Metformin Hcl	150	26
Mirtazapine	Mirtazapine	143	13
Losartan Potassium	Losartan Potassium	141	20
Clopidogrel	Clopidogrel Bisulfate	117	17
Donepezil Hcl	Donepezil Hcl	113	14
Ibuprofen	Ibuprofen	109	27
Quetiapine Fumarate	Quetiapine Fumarate	105	13
Sertraline Hcl	Sertraline Hcl	101	14
Escitalopram Oxalate	Escitalopram Oxalate	100	13
Famotidine	Famotidine	91	20
Latanoprost	Latanoprost	86	15
Myrbetriq	Mirabegron	86	15
Oxybutynin Chloride Er	Oxybutynin Chloride	84	11
Zolpidem Tartrate	Zolpidem Tartrate	82	12
Nifedipine Er	Nifedipine	78	suppressed
Loperamide	Loperamide Hcl	70	33
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	suppressed
Spironolactone	Spironolactone	61	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	60	suppressed
Potassium Chloride	Potassium Chloride	59	13
Trazodone Hcl	Trazodone Hcl	59	suppressed
Levetiracetam	Levetiracetam	58	suppressed
Jardiance	Empagliflozin	55	suppressed
Alendronate Sodium	Alendronate Sodium	54	12
Oxybutynin Chloride	Oxybutynin Chloride	54	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	suppressed
Allopurinol	Allopurinol	49	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	49	suppressed
Carvedilol	Carvedilol	49	suppressed
Finasteride	Finasteride	49	suppressed
Chlorthalidone	Chlorthalidone	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	11
Memantine Hcl	Memantine Hcl	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	47	suppressed
Oxycodone Hcl	Oxycodone Hcl	47	14
Warfarin Sodium	Warfarin Sodium	47	suppressed
Simvastatin	Simvastatin	46	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Single Use Swab	Alcohol Antiseptic Pads	44	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Divalproex Sodium	Divalproex Sodium	38	suppressed
Entresto	Sacubitril/Valsartan	37	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	suppressed
Meloxicam	Meloxicam	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Bumetanide	Bumetanide	34	suppressed
Mupirocin	Mupirocin	34	17
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Aripiprazole	Aripiprazole	32	suppressed
Clonazepam	Clonazepam	32	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	suppressed
Lumigan	Bimatoprost	31	suppressed
Methadone Hcl	Methadone Hcl	31	suppressed
Prednisone	Prednisone	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Xarelto	Rivaroxaban	25	suppressed
Atenolol	Atenolol	24	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Nystatin	Nystatin	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Combigan	Brimonidine Tartrate/Timolol	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	13
Torsemide	Torsemide	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Folic Acid	Folic Acid	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	12
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Restasis	Cyclosporine	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Prednisolone Acetate	Prednisolone Acetate	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Risperidone Er	Risperidone Microspheres	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Digoxin	Digoxin	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	12	suppressed
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	12	suppressed
Baclofen	Baclofen	11	suppressed
Entecavir	Entecavir	11	suppressed
Galantamine Er	Galantamine Hbr	11	suppressed
Klor-Con M15	Potassium Chloride	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Mesalamine Dr	Mesalamine	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error